Abstract: Provided a method for setting up an authorization verification for a first device, for example a field device in an automation system, wherein the first device is configured by configuration data transmitted to the first device from a configuration module that is detachably connected to the first device and, for example, is implemented in the form of an SD card or a USB stick, having: detection of a connection of a configuration module to the first device, reading configuration module-specific device information from the configuration module, requesting configuration module-specific authorization verification for the configuration model-specific device information from the first device in an authorization device, and storing the requested configuration module-specific authorization verification on a security storage unit of the first device.

Abstract: The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. The disclosure provides novel compositions comprising non-pathogenic fecal microbes for treating epilepsy, epileptic seizures and related diseases. The disclosure also provides methods for treating a subject with the compositions disclosed herein.

Abstract: A blockchain smart contract rewriting framework system has a vulnerability detection tool, a rewriter tool, and a deployment component. The deployment component obtains a permission to upgrade the smart contract, which granted by a smart contract creator/owner. The contract rewriting framework system retrieves the smart contract from the blockchain network, and passes it to the vulnerability detection tool. The vulnerability detection tool detects a vulnerability in the smart contract, and determines a type of the vulnerability and an instruction location of the vulnerability. The rewriter tool rewrites the smart contract to include a patch for fixing the vulnerability, a patched smart contract being generated by the rewriter tool based on the type of the vulnerability and the instruction location of the vulnerability.

Abstract: The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.

Abstract: A method of taking a skin sample can include placing an adhesive onto a portion of skin and lifting the adhesive from the skin. A skin sample may then be tested while still on the adhesive, for example, by inoculating the sample with a bacterium, fungus, virus, or a combination.

Abstract: A transmitting and receiving antenna system of an LPWAN repeater, according to the present invention, comprise: a first antenna and a second antenna that become a transmitting antenna according to a use's setting; a switch coupled to each of the first antenna and the second antenna; a third antenna for reception; an RF receiving end connected to the third antenna for reception; and a control unit for controlling the RF transmitting end and the RF receiving end through switching of the switch, wherein the first antenna is a dipole antenna having multiple directionalities, the second antenna is a directional patch antenna for transmitting signals in one orientational direction, and the third antenna includes an omni-directional antenna.

Abstract: Systems, apparatuses and methods provides for technology that generates, with a phased array of elements of an antenna system, an array element radiation pattern over a scan angle range, where the phased array of elements is spaced at a predetermined wavelength spacing. The technology reflects, with a reflector of the antenna system, the array element radiation pattern emitted from the phased array of elements to Earth, and establishes, based on a shape of the reflector, a predetermined magnification as a function of scan angle range so as to increase the field-of-view of the antenna system. The technology adjusts, based on the shape of the reflector, the array element radiation pattern, by increasing magnification relative to the scan angle range, to have a gain that increases with increases in scan angle relative to a boresight of the antenna system, and reflects, with the reflector, radiation from Earth to the phased array of elements.

Abstract: An electronic device and method for forming a housing of the same is disclosed. The electronic device includes: a housing including: a first plate forming a front surface of the housing, a second plate integrally forming a rear surface and side surface of the housing, wherein a space is enclosed between the front surface, side surface and rear surface, and wherein the second plate includes a first surface forming the side and rear surfaces of the housing, and a second surface disposed opposite to the first surface, and a display disposed in the space and at least partially visible through the first plate, wherein at least a portion of the second surface includes a pattern having surface roughness having a height of 0.1 ?m to 1 ?m.

Abstract: Provided herein are recombinant fusion polypeptides comprising one or more antigenic peptides (e.g., fused to a PEST-containing peptide) from cancer-associated proteins. The antigenic peptides can comprise one or more or all of an antigenic peptide comprising a recurrent cancer mutation, an antigenic peptide comprising a heteroclitic mutation, or an antigenic peptide fused to a ubiquitin protein. For example, provided herein are recombinant fusion polypeptides comprising two or more antigenic peptides (e.g., fused to a PEST-containing peptide), wherein each antigenic peptide comprises a recurrent cancer mutation, and wherein at least two of the antigenic peptides are fragments of the same cancer-associated protein. Also provided are nucleic acids encoding such fusion polypeptides, recombinant bacteria or Listeria strains comprising such fusion polypeptides or such nucleic acids, and cell banks comprising such recombinant bacteria or Listeria strains.

Abstract: The present invention relates to vesicles derived from genus Morganella bacteria and a use thereof, the present inventors experimentally confirmed that the vesicles were significantly decreased in clinical samples derived from patients with a malignant disease such as gastric cancer, colorectal cancer, pancreatic cancer, bile duct cancer, breast cancer, ovarian cancer, bladder cancer, prostate cancer and lymphoma, a cardiovascular disease such as myocardial infarction, cardiomyopathy, atrial fibrillation, variant angina, and stroke, diabetes mellitus, and Parkinson's disease as compared to normal persons, and the vesicles suppressed the secretion of inflammatory mediators by pathogenic vesicles and suppressed the occurrence of cancer, so that the vesicles derived from genus Morganella bacteria may be usefully used for the purpose of developing a method for diagnosing a malignant disease such as gastric cancer, colorectal cancer, pancreatic cancer, bile duct cancer, breast cancer, ovarian cancer, bladder cance

Abstract: The invention provides propagator cells and methods for propagating phage and transduction particles.

Abstract: A communication assembly includes a housing, a communication device, an extendable mast, and a control circuit. The housing is configured to be mounted on a vehicle. The communication device includes an antenna and is disposed at least partially within the housing. The extendable mast is mechanically coupled to the housing and supports the antenna. The control circuit is operably coupled to the mast and is configured to generate a signal to raise the mast from a first position of a distal end of the mast to a second position of the distal end in response to determining occurrence of a designated raise event. The antenna extends a greater distance from the housing in the second position of the mast than in the first position.

Abstract: Provided are vesicles derived from bacteria belonging to the genus Proteus and a use thereof. The inventors of the present invention experimentally confirmed that the vesicles was significantly reduced in samples of patients with cancers, allergic-respiratory diseases, cardiovascular diseases, metabolic diseases, or neuropsychiatric diseases, as compared to that of normal people, and the vesicles inhibited the secretion of inflammatory mediators due to pathogenic vesicles and also exhibited anticancer efficacy. Therefore, it is anticipated that the vesicles derived from bacteria belonging to the genus Proteus, according to the present invention, may be usefully used for the development of a method of diagnosing cancer, cardiovascular diseases, metabolic diseases, neuropsychiatric diseases, allergic-respiratory diseases, and inflammatory bowel diseases, and a composition for prevention, treatment, and/or alleviation.

Abstract: Envelope tracking schemes for Doherty power amplifiers are provided herein. In certain embodiments, an envelope tracking system includes a carrier amplifier that amplifies a first radio frequency signal, a peaking amplifier that amplifies a second radio frequency signal corresponding to a delayed version of the first radio frequency signal, an envelope tracker that generates a first power supply voltage that powers the carrier amplifier, and a delay circuit that delays the first power supply voltage to generate a second power supply voltage that powers the peaking amplifier. The envelope tracker controls a voltage level of the first power supply voltage to track an envelope of the first radio frequency signal. Thus, supply modulation is used to achieve gains in linearity, efficiency, and/or other performance metrics.

Abstract: An antenna array has a plurality of square or rectangular antenna assemblies. Each assembly includes a first antenna assembly surface with a solar cell and a second antenna assembly with one or more antenna elements. The antenna assemblies are interconnected without gaps therebetween to form a first contiguous array surface comprised of the first antenna assembly surfaces and a second contiguous array surface comprised of the second antenna assembly surfaces. The antenna assemblies are connected together by mechanically stored-energy connectors, such as spring tape, that self-deploy the array in space without the use of electric energy.

Abstract: The present invention relates to, in part, compositions and methods for delivery of novel mixtures of bacterial strains for maintaining and/or restoring a healthy gut barrier.

Abstract: The present disclosure is directed to antennas for transmitting and/or receiving electrical signals comprising a MXene composition, devices comprising these antennas, and methods of transmitting and receiving signals using these antennas.

Abstract: Wireless receiver systems and methods for user equipment are described that employ multiple receiver heads. The multiple heads can receive wireless communication signals over different receive paths from different transmission sources. The systems can scan and monitor signal quality from all receiver heads during a scheduled gap in a communication link without interfering with an ongoing communication session.

Abstract: Provided is a display apparatus including a display panel, multiple antenna electrodes, a dummy electrode, and multiple feed lines. The display panel has a display area. The antenna electrodes are disposed on the display panel and overlap the display area. The dummy electrode is disposed around the antenna electrodes and overlaps the display area. The dummy electrode is electrically separated from the antenna electrodes, and has multiple dummy wire segments whose extension directions intersect each other. The dummy wire segments have multiple breaks. The feed lines are respectively electrically connected to the antenna electrodes. An antenna module is also provided.

Abstract: A selective microbial detection device and methods of use are provided. The device includes a water-proof pouch that includes a first wall portion, a second wall portion, and a porous membrane filter disposed in the pouch between the first and second wall portions. The filter membrane divides the pouch into first and second compartments. The microbial detection device also includes an effective amount of a dry nutrient disposed in the first compartment, which contains sodium lauryl sulfate in an amount of 1.75 milligrams or greater per twelve square inches of the first wall portion. A dry, cold water-soluble gelling agent is adhered to the pouch in the first compartment and an absorbent pad is disposed in the second compartment. A sealable sample port provides access to deposit a liquid into the first compartment.